作者
Nedime Serakinci, Rikke Christensen, Umut Fahrioglu, Flemming Brandt Sorensen, Frederik Dagnæs-Hansen, Miroslav Hajek, Tinna Herløv Jensen, Steen Kolvraa, Nicol W Keith
发表日期
2011/12/1
期刊
Cancer Biotherapy and Radiopharmaceuticals
卷号
26
期号
6
页码范围
767-773
出版商
Mary Ann Liebert, Inc.
简介
The field of stem cell biology continues to evolve by characterization of further types of stem cells and by exploring their therapeutic potential for experimental and clinical applications. Human mesenchymal stem cells (hMSCs) are one of the most promising candidates simply because of their easiness of both ex vivo expansion in culture dishes and genetic manipulation. Despite many extensive isolation and expansion studies, relatively little has been done with regard to hMSCs' therapeutic potential. Although clinical trials using hMSCs are underway, their use in cancer therapy still needs better understanding and in vivo supporting data. The homing ability of hMSCs was investigated by creating a human xenograft model by transplanting an ovarian cancer cell line into immunocompromised mice. Then, genetically engineered hMSC-telo1 cells were injected through the tail vein and the contribution and distribution …
引用总数
2012201320142015201620172018201920202021202220232024754661354221
学术搜索中的文章
N Serakinci, R Christensen, U Fahrioglu, FB Sorensen… - Cancer Biotherapy and Radiopharmaceuticals, 2011